SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-026966
Filing Date
2021-05-17
Accepted
2021-05-17 16:00:41
Documents
46
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_alphahealthcare.htm 10-Q 307431
2 CERTIFICATION f10q0321ex31-1_alphahealth.htm EX-31.1 11743
3 CERTIFICATION f10q0321ex31-2_alphahealth.htm EX-31.2 11739
4 CERTIFICATION f10q0321ex32-1_alphahealth.htm EX-32.1 4504
5 CERTIFICATION f10q0321ex32-2_alphahealth.htm EX-32.2 4513
  Complete submission text file 0001213900-21-026966.txt   2094220

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ahacu-20210331.xml EX-101.INS 206206
7 XBRL SCHEMA FILE ahacu-20210331.xsd EX-101.SCH 34887
8 XBRL CALCULATION FILE ahacu-20210331_cal.xml EX-101.CAL 16449
9 XBRL DEFINITION FILE ahacu-20210331_def.xml EX-101.DEF 157681
10 XBRL LABEL FILE ahacu-20210331_lab.xml EX-101.LAB 262887
11 XBRL PRESENTATION FILE ahacu-20210331_pre.xml EX-101.PRE 161083
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10105
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10105 6463213444
Alpha Healthcare Acquisition Corp. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39532 | Film No.: 21930139
SIC: 2836 Biological Products, (No Diagnostic Substances)